GlaxoSmithKline plc (ADR) (NYSE:GSK)

CAPS Rating: 3 out of 5

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products.

GSK News and Commentary

Caps

How do you think GSK will perform against the market?

Add Stock to CAPS Watchlist

All Players

1,400 Outperform
88 Underperform
 

All-Star Players

310 Outperform
24 Underperform
 

Wall Street

13 Outperform
6 Underperform
 

Top GSK Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

brokhernowhysher (65.55)
Submitted November 12, 2015

I am a long term investor who appreciates high dividends. Everything I have seen from GSK indicates a company that while struggling currently, has a good long term outlook. They pay a 5% + dividend and management is bullish on their ability to… More

Funzer (< 20)
Submitted November 16, 2007

GSK is revising Avandia product label to reflect negative events such as myocardial ischemia. Since there is no reduction in cardiovascular risks for diabetics, this reduces the long term outlook for the profitablity of this drug product and GSK.

GSK VS S&P 500 (SPY)

Fools bullish on GSK are also bullish on:

Fools bearish on GSK are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about GSK.

Recs

0
Member Avatar TMFGBudwell (69.04) Submitted: 10/30/2017 6:29:53 AM : Outperform Start Price: $35.10 GSK Score: +9.59

Improving fundamentals, new management.

Recs

0
Member Avatar superstar (99.85) Submitted: 8/23/2017 7:06:06 PM : Underperform Start Price: $37.63 GSK Score: +3.67

GlaxoSmithKline is at the forefront of some interesting R&D, but the amount of debt facing this company would really make me nervous as an investor. I'd avoid this one in my portfolio. It only makes sense to invest in healthcare stocks with high debt loads if the company is in the small or midcap space. Once a company reaches a market cap of 100 billion with an enormous debt load to match, it almost becomes impossible for the company to pay off that level of debt-- even if it has some surprise success stories in its pipeline going forward.

Recs

0
Member Avatar lifeboy (61.24) Submitted: 12/3/2016 12:25:15 AM : Outperform Start Price: $34.85 GSK Score: -7.20

Seems undervalued for being a major pharma player.

Leaderboard

Find the members with the highest scoring picks in GSK.

Score Leader

niwhsa

niwhsa (80.25) Score: +150.26

The Score Leader is the player with the highest score across all their picks in GSK.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
niwhsa 80.25 11/20/2008 Underperform 3Y $20.29 +101.09% +251.35% +150.26 0 Comment
stockpickeraz 27.40 1/16/2009 Underperform 5Y $21.83 +86.95% +230.68% +143.73 0 Comment
lwc123 40.56 1/8/2009 Underperform 3Y $23.44 +74.08% +209.54% +135.46 0 Comment
stoneyg72 83.18 4/1/2009 Underperform 3W $18.75 +117.66% +244.11% +126.45 0 Comment
longterm007 85.05 10/31/2008 Underperform 5Y $23.08 +76.79% +195.61% +118.82 0 Comment
TRGoodvsEvil 97.27 7/6/2009 Underperform 5Y $21.21 +92.40% +209.83% +117.42 0 Comment
MIKEP75731 32.59 5/22/2009 Underperform 5Y $20.34 +100.65% +211.32% +110.67 1 Comment
janiceelaine < 20 10/6/2008 Underperform 3Y $25.20 +61.92% +162.59% +100.66 0 Comment
PurePwnage 98.62 11/27/2009 Underperform 5Y $26.13 +56.19% +152.99% +96.80 0 Comment
Durp 83.63 9/15/2006 Underperform 3W $30.32 +34.62% +121.83% +87.21 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 85.44 3/24/2016 Underperform 3W $35.19 +15.98% +35.01% +19.04 0 Comment
TrackBofASec 94.02 12/9/2014 Underperform NS $36.59 +11.52% +34.19% +22.67 0 Comment
TrackArgus 86.55 4/23/2014 Outperform NS $43.57 -6.34% +46.02% -52.36 0 Comment
TrackCowenandCo 83.29 8/22/2013 Outperform NS $51.26 +6.81% +11.84% -5.02 1/22/2014 @ $54.75 0 Comment
TrackDeutscheSec 87.53 5/28/2013 Outperform NS $52.69 -3.38% +6.96% -10.34 12/17/2013 @ $50.91 0 Comment
TrackJimCramer 85.44 4/10/2013 Outperform 3W $40.24 -1.69% +28.01% -29.70 3/24/2016 @ $39.56 0 Comment
TrackExaneBNP 43.00 9/19/2012 Underperform NS $34.06 +19.81% +86.82% +67.01 0 Comment
TrackJPMorgan 87.14 8/22/2012 Underperform NS $33.25 +22.73% +93.95% +71.22 0 Comment
TrackZacks < 20 7/12/2012 Underperform 3M $43.98 +5.71% +6.01% +0.30 8/27/2012 @ $46.49 1 Comment
TrackPoisedTo < 20 4/26/2012 Outperform 5Y $32.53 +25.47% +97.45% -71.98 0 Comment
TrackZacks < 20 4/24/2012 Outperform 3M $46.64 -2.45% -0.94% -1.51 5/10/2012 @ $45.50 1 Comment
TrackWayneRogers 67.40 12/16/2011 Outperform 3M $31.37 +30.07% +125.54% -95.47 0 Comment
TrackUltraLong < 20 11/2/2011 Underperform NS $30.23 +35.00% +121.46% +86.46 1 Comment
TrackGoldmanSach 81.80 6/13/2011 Underperform 5Y $28.61 +42.65% +114.43% +71.78 1 Comment
TrackJefferies 83.64 6/2/2010 Outperform NS $22.25 +83.44% +153.74% -70.30 0 Comment
TrackCreditSuiss 90.77 3/4/2010 Underperform NS $28.18 +46.27% +80.67% +34.40 10/20/2015 @ $41.23 0 Comment
TrackZacks < 20 1/25/2010 Underperform 3M $39.85 -3.10% +10.25% +13.35 4/22/2010 @ $38.61 1 Comment
TrackDreman 33.26 9/30/2009 Outperform NS $24.55 +66.21% +167.61% -101.40 0 Comment
TrackJimCramer 85.44 5/29/2009 Underperform 3W $27.61 +72.96% +71.48% -1.48 4/10/2013 @ $47.75 0 Comment
TrackCreditSuiss 90.77 3/17/2009 Outperform NS $27.89 +49.27% +49.71% -0.44 1/13/2010 @ $41.63 0 Comment
TrackTobinSmith < 20 3/6/2009 Outperform 1Y $17.41 +134.39% +304.96% -170.57 0 Comment
TrackJefferies 83.64 1/26/2009 Outperform NS $34.04 +19.73% +30.86% -11.13 10/23/2009 @ $40.76 0 Comment
TrackJimCramer 85.44 12/23/2008 Outperform 3W $34.88 -3.35% +7.39% -10.74 5/29/2009 @ $33.71 0 Comment
TrackBillNygren 97.50 6/19/2008 Outperform 5Y $25.66 +59.04% +112.03% -52.99 2 Comments
TrackBerkowitz 86.07 5/27/2008 Outperform 1Y $25.54 +59.81% +106.38% -46.57 1 Comment
TrackJimCramer 85.44 5/5/2008 Underperform 3W $43.85 -18.27% -38.82% -20.55 12/24/2008 @ $35.84 0 Comment
TrackUBS 92.10 2/11/2008 Outperform NS $40.78 -10.15% -32.19% +22.04 11/14/2008 @ $36.64 0 Comment
TrackJohnKeeley < 20 9/30/2007 Outperform NS $29.94 +36.30% +88.31% -52.01 1 Comment
TrackDodgeCox 92.67 9/30/2007 Outperform NS $29.94 +36.30% +88.31% -52.01 3 Comments
TrackBrandes < 20 9/30/2007 Outperform NS $29.94 +36.30% +88.31% -52.01 2 Comments
TrackNWQ < 20 9/30/2007 Outperform NS $29.94 +36.30% +88.31% -52.01 1 Comment
TrackEdwardOwens 98.92 9/30/2007 Outperform NS $29.94 +36.30% +88.31% -52.01 2 Comments
TrackSnow 76.33 9/30/2007 Outperform NS $48.19 -16.88% -33.29% +16.42 8/21/2009 @ $40.06 5 Comments
TrackBearStearns < 20 7/25/2007 Underperform NS $41.67 +9.60% -9.18% -18.77 4/17/2012 @ $45.67 0 Comment
TrackJPMorgan 87.14 3/22/2007 Underperform NS $48.10 -19.18% -24.34% -5.16 2/16/2010 @ $38.87 0 Comment
TrackBearStearns < 20 9/19/2006 Underperform NS $54.42 +4.12% +9.95% +5.84 2/9/2007 @ $56.66 0 Comment
TrackJimCramer 85.44 6/2/2006 Outperform 3W $52.54 -14.56% +8.75% -23.30 5/6/2008 @ $44.89 0 Comment

Featured Broker Partners


Advertisement